Matching-adjusted indirect comparisons of efficacy and safety for zanubrutinib versus the combination of fixed-duration venetoclax and ibrutinib in patients with treatment-naive chronic lymphocytic leukaemia.
No Thumbnail Available
All Authors
Munir, T.
Mohseninejad, L.
Rakonczai, P.
Dobi, B.
Xu, S.
Yang, K.
Vezan, R.
Calle, NM.
LTHT Author
Munir, Talha
LTHT Department
Oncology
Haematology
Haematology
Non Medic
Publication Date
2025
Item Type
Journal Article
Language
Subject
Subject Headings
Abstract
Journal
British Journal of Haematology